Search Results - "Klyasova, G A"

Treatment of candidemia caused by Candida albicans and Candida non - albicans in patients with hematological malignancies by Klyasova, G A, Malchikova, A O, Tandilova, K S, Blohina, E V, Parovichnikova, E N, Kravchenko, S K, Savchenko, V G

“…Aim. To study the risk factors, symptoms and outcomes of candidemia caused by C. albicans and C. non - albicans in patients with hematological malignancies…”
Get full text

Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure by Firsova, M V, Mendeleeva, L P, Solovev, M V, Rekhtina, I G, Pokrovskaya, O S, Urnova, E S, Soboleva, N P, Dvirnyk, V N, Klyasova, G A, Kuzmina, L A, Savchenko, V G

“…To assess the safety and efficacy of autologous haematopoietic stem cell transplantation (auto-HSCT) in multiple myeloma (MM) patients with dialysis-dependent…”
Get full text

Novel treatment possibilities of invasive aspergillosis by Klyasova, G. A.

“…Invasive aspergillosis is the leading fungal infection in patients with hematological malignancies. The review represents the incidence of invasive…”
Get full text

Current treatment options for infections caused by carbapenem-resistant Enterobacteriaceae in patients with hematological malignancies by Klyasova, G. A.

“…Infections are a common complication in patients with hematological malignancies, especially during neutropenia. Recently, an increase in multidrug-resistant…”
Get full text

Perianal infection in patients with hemoblastosis: Risk factors and possibilities of prevention by Shtyrkova, S V, Klyasova, G A, Ntanishyan, K I, Gemdzhian, E G, Troitskaya, V V, Karagyulyan, S R

“…to identify poor prognostic factors for perianal infection (PI) in patients with hemoblastosis and to define an effective tactic for preventive and therapeutic…”
Get full text

Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia by Nesterova, E S, Kravchenko, S K, Mangasarova, Ya K, Baryakh, E A, Misyurina, A E, Vorobyev, V I, Plastinina, L V, Chernova, N G, Kovrigina, A M, Obukhova, T N, Klyasova, G A, Shevelev, A A, Kostina, I E, Gemdzhian, E G, Gaponova, T V, Vorobyev, A I

“…to evaluate the efficiency of high-dose chemotherapy (HDCT) with further autologous blood stem cell transplantation (auto-BSCT) in the first-line therapy of…”
Get full text

Factors influencing recovery in patients with hemoblastoses and candidemia by Klyasova, G A, Blokhina, E V, Gracheva, A N, Kravchenko, S K, Parovichnikova, E N, Okhmat, V A, Korobova, A G, Galstyan, G M, Kulikov, S M

“…aim: To study the factors influencing the results of treatment for candidemia (CE) in patients with blood system tumors. The investigation enrolled patients…”
Get full text

Diagnosis and treatment in patients with B-cell lymphoma unclassified that is intermediate between diffuse large B-cell lymphoma and Burkitt’s lymphoma by E A Baryakh, A E Misyurina, A M Kovrigina, T N Obukhova, E G Gemdzhyan, V I Vorobyev, Ya K Mangasarova, Yu Yu Polyakov, A U Magomedova, G A Klyasova, V A Misyurin, G A Yatsyk, A A Shevelev, I E Kostina, A I Vorobyev, S K Kravchenko

“…Aim. To characterize a group of patients with B-cell lymphoma (BCLU) unclassified that is intermediate between diffuse large B-cell lymphoma and Burkitt’s…”
Get full text

Therapy for Burkitt's lymphoma according to the BL-M-04 protocol: 12-year experience by Baryakh, E A, Tyurina, N G, Vorobyev, V I, Gemdzhyan, E G, Mangasarova, Ya K, Klyasova, G A, Kovrigina, A M, Obukhova, T N, Zvonkov, E E, Vernyuk, M A, Chervontseva, A M, Polyakov, Yu Yu, Misyurina, А Е, Valiev, T T, Zherebtsova, V A, Magomedova, A U, Galstyan, G M, Yatskov, K V, Nesterova, E S, Vorobyev, A I, Kravchenko, S K

“…To evaluate the efficiency and toxicity of the intensive Burkitt's lymphoma (BL) therapy protocol BL-M-04. A total of 70 patients diagnosed with BL, including…”
Get full text

Risk of bloodstream infections in allogeneic hematopoietic cell transplant recipients according to gut mucosal colonization and fluoroquinolone implementation during neutropenia by Klyasova, G. A., Akhmedov, M. I., Kuzmina, L. A., Fedorova, A. V., Mironova, D. A., Parovichnikova, E. N.

“…Background. Higher rate of gram-negative bloodstream infections (BSI) have been recently documented from transplantation centers providing fluoroquinolone (FQ)…”
Get full text

Infectious complications caused by carbapenemase-producing Enterobacterales in patients with hematological disorders by Tandilova, K. S., Klyasova, G. A.

“…Mortality rates approaching 60 % have been reported in hematological patients with infections caused by carbapenemase-producing Enterobacterales. The incidence…”
Get full text

In vitro activity of cefepime / sulbactam and biapenem against Enterobacterales and Pseudomonas aeruginosa isolated from blood culture from patients with hematological diseases: results of a multicenter study by Klyasova, G. A., Fedorova, A. V., Khrulnova, S. A., Frolova, I. N., Vetokhina, A. V., Molchanova, I. V., Kutsevalova, O. Yu

“…Background. Activity against Gram negative bacteria, including Pseudomonas aeruginosa , is required for first line antibiotic therapy in patients with febrile…”
Get full text

Genotyping by Random Amplified Polymorphic DNA Assay of Acinetobacter baumannii Isolated from Blood Culture of Patients with Hematological Malignancies by Khrulnova, S. A., Fedorova, A. V., Frolova, I. N., Klyasova, G. A.

“…Relevance. Acinetobacter baumannii is a significant nosocomial pathogen that can cause severe infections, especially in immunocompromised patients. Aims. This…”
Get full text

Bloodstream infections in different stage of reconstitution after first allogeneic hematopoietic stem cell transplantation by Akhmedov, M. I., Klyasova, G. A., Parovichnikova, E. N., Kuzmina, L. A., Fedorova, A. V., Vasil’eva, V. A., Drokov, M. Yu, Kulikov, S. M., Savchenko, V. G.

“…Background . Bloodstream infections (BSI) are common after allogeneic hematopoietic stem cell transplantation (allo-HSCT). The objective of study was to…”
Get full text

Change in the Clonal Structure of Carbapenem not Susceptible Acinetobacter baumannii Isolated from the Blood Culture of Patients with Hematological Malignancies by Khrulnova, S. A., Korobova, A. G., Fedorova, A. V., Frolova, I. N., Klyasova, G. A.

“…The emergence and dissemination of successful clones of A. baumannii is a serious problem for the medical community. To investigate the clonal diversity of A…”
Get full text

Antimicrobial resistance of Enterococcus faecium and Enterococcus faecalis, isolated from blood culture of patients with hematological malignancies during different study periods by Fedorova, A. V., Klyasova, G. A., Frolova, I. N., Khrulnova, S. A., Vetokhina, A. V., Kaporskaya, T. S., Molchanova, I. V., In hematology, Russian Group For bloodstream infection

“…Objective : to determine antimicrobial resistance of Enterococcus faecium and Enterococcus faecalis isolated from blood culture of hematological patients…”
Get full text

Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli collected from patients with hematological malignancies during chemotherapy cycles by Korobova, A. G., Khrulnova, S. A., Tandilova, K. S., Novikova, A. A., Klyasova, G. A.

“…Objective: to evaluate the genetic relatedness of extended-spectrum β -lactamase (ESBL) producing Escherichia coli isolated from the gut in patients with acute…”
Get full text

Infectious complications in patients with multiple myeloma on first chemotherapy cycle by Novikova, A. A., Klyasova, G. A., Gribanova, E. O., Okhmat, V. A., Ryzhko, V. V., Savchenko, V. G.

“…The aim of the study was to evaluate the profile and risk factors for acquisition of infections in patients with de novo multiple myeloma (MM) on the 1st…”
Get full text

THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA by Klyasova, G. A., Okhmat, V. A., Parovichnikova, E. N., Gribanova, E. O., Troitskaya, V. V., Savchenko, V. G.

“…Efficacy of posaconazole for prophylaxis was evaluated in 77 chemotherapy cycles in 59 patients with acute myeloid leukemia (AML) aged 39 (17–62) years from…”
Get full text

Infectious complications in patients with acute leukemia according to the duration of neutropenia by Okhmat, V. A., Klyasova, G. A., Parovichnikova, E. N., Dvirnik, V. N., Troitskaya, V. V., Gribanova, E. O., Savchenko, V. G.

“…Introduction. Patients with hematological malignancies undergoing chemotherapy (CT) have high incidence of infections which profile is affected by various…”
Get full text